Off-label drug use among hospitalized children: identifying extent and nature

J. Slažneva 1 , L. Kovács 2 , and M. Kuželová 1
  • 1 Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava
  • 2 Second Department of Paediatrics, Comenius University Medical School, Children's University Hospital, Bratislava

Off-label drug use among hospitalized children: identifying extent and nature

Objective of the study was to determine the extent and nature of medicinal products used off-label in hospitalized children and to highlight the therapeutic areas with the highest need. Over a 4 week period, data about prescribed drugs to patients under 18 years of age at two paediatric wards in Bratislava (Unit for Infants and Unit for Older Children) were recorded and the drug-licensing status according to valid Summary of Product Characteristics (SPC) was identified. In total, 206 medicinal products containing 70 different generic substances were given to 49 paediatric patients at the Unit for Infants. Of these, 22% were evaluated as off-label. The highest rates were established among the drugs used for diseases of respiratory system and diseases of digestive system. The 68 children had been given at the Unit for Older Children 267 medicinal products resulting in 97 generic substances. In 15.7% of cases medicines were used in off-label manner, mainly due to unapproved paediatric indication and age. This pilot study provided a preliminary survey on drugs administered off-label to paediatric patients in Slovak Republic.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Bush A. Evidence-based medicines for children: important implications for new therapies at all ages. Eur Respir J. 2006;28:1069-1072.

  • Conroy S, Impicciatore P, Mohn A, Arnell H, Rane A, Knoeppel C, Seyberth H, Pandolfini CH, Raffaelli MP, Rocchi F, Bonati M, Jong G, Hoog M, Van Den Anker J. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320:79-81.

  • Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Fetal Neonatal Ed. 1999;80:F142-F145.

  • Dell'Aera M, Gasborro AR, Padovano M, Laforgia N, Capodiffiero D, Solarino B, Quaranta R, Dell'Erba AS. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci. 2007;29:361-367.

  • Hsien L, Breddemann A, Frobel AK, Heusch A, Schmidt KG, Laer S. Off-label drug use among hospitalized children: identifying areas with highest need for research. Pharm World Sci. 2008;30:497-502.

  • Khdour MR, Hallak HO, Alaysa KSA, Aishahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalized children in Palestine. Int J Clin Pharm. 2011;33:650-655.

  • Lindell-Ouagwu L, Koronen MJ, Saano S, Hellin-Tanninen M, Naaranlahti T, Kokki H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J Clin Pharm Ther. 2009;34:277-287.

  • Pandolfini C, Impicciatore P, Provasi D, Rocchi F, Campi R, Bonati M, The Italian Paediatric off-label collaborative group. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr. 2002;91:339-347.

  • Pandolfini Ch, Bonati M. A literature review on off-label drug use in children. Eur J Paediatr. 2005;164:552-558.

  • Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 49. Available at:

  • Report on survey of all paediatric uses of medicinal products in Europe. EMA/794083/2009, 2011:1-37.

  • T Jong GW, Vulto AG, De Hoog M, Schimmel KJM, Tibboel D, Van Den Anker J. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Paediatrics. 2001;108:1089-1093.


Journal + Issues